WSGR logoWSGR logo
Emily Shingle
Associate
Litigation
San Diego

D858-350-2341

Download vCard
Open PDF

Emily Shingle is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patent litigation group.

Experience

Emily Shingle is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patent litigation group.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Azurity on Litigation Matters Related to Covis Pharma Acquisition
On March 14, 2025,  Azurity Pharmaceuticals announced the successful completion of its acquisition of Covis from existing investors. With this acquisition, Covis is now a wholly owned subsidiary of Azurity. Wilson Sonsini Goodrich & Rosati advised Azurity on litigation matters related to the transaction.
Learn More
Alerts
FDA Announced Removal of Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and weight-loss tirzepatide injection products (Mounjaro and Zepbound; Eli Lilly and Company) has been resolved. The declaratory order revokes and replaces the agency’s October 2, 2024, decision on the same subject after a court remanded the decision to the agency for reevaluation.1
Learn More
WSGR logo
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.